Research workspace

Finance

Public market data, research, and analysis in one place.

Finance home
Back to HK Equities

HK Equities · Finance research note

HKEX 6823 - HKT Ltd.

Research and analysis only
View analysis Browse HK Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

1. Industry Fundamentals

1.1 Cyclicality

The company operates in a cyclical industry sensitive to macroeconomic conditions. Revenue and earnings tend to correlate with broader economic cycles, with periods of expansion driving growth and contractions creating headwinds. Current market capitalisation: 92.05 B.

1.2 Competition

The industry is moderately competitive with established players and meaningful barriers to entry. Beta of N/A suggests moderate market sensitivity. Competitive advantages stem from brand, scale, or regulatory moats.

1.3 Technology

Key technology drivers include digital transformation, operational efficiency, automation. Companies that invest in R&D and adopt new technologies tend to gain market share. The pace of technological change creates both opportunities for innovation and risks of disruption.


2. Company Fundamentals

2.3 Management

RoleMetric
Consensus RatingN/A

2.4 Return

MetricValue
Expected Return (Ann.)17.39%
Risk / Std Dev (Ann.)16.05%

Price Snapshot:

MetricValue
Last Price12.140 HKD
Day Change+0.040 (+0.33%)

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in HK$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont componentCalculationFY2025FY2024
RevenueReported revenueHK$36.55BHK$34.75B
Net incomeReported net incomeHK$5.29BHK$5.07B
Total assetsYear-end reported balanceHK$121.15BHK$116.81B
Shareholders’ equityYear-end reported balanceHK$36.82BHK$38.28B
Net marginNet income ÷ revenue14.46%14.59%
Asset turnoverRevenue ÷ total assets0.3017x0.2975x
Equity multiplierTotal assets ÷ shareholders’ equity3.2903x3.0514x
ROENet margin × asset turnover × equity multiplier14.36%13.24%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating inputValue
RevenueHK$36.55B
Prior annual revenueHK$34.75B
EBITHK$8.35B
Tax rate13.59%
NOPAT = EBIT × (1 − tax rate)HK$7.21B
Forecast start-growth basis5.18%
Forecast policylatest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building blockValue
NOPATHK$7.21B
Add: depreciation & amortisationHK$5.84B
Less: capital expenditure-HK$5.53B
Less/(add): working-capital cash-flow movement-HK$2.53B
Current unlevered FCFFHK$4.99B

Explicit FCFF forecast

Forecast yearRevenue growthNOPATD&ACapexChange in NWCFCFFPresent value
15.18%HK$7.59BHK$6.14B-HK$5.82B-HK$2.66BHK$5.25BHK$5.10B
24.51%HK$7.93BHK$6.42B-HK$6.17B-HK$2.78BHK$5.40BHK$4.96B
33.84%HK$8.23BHK$6.66B-HK$6.49B-HK$2.88BHK$5.52BHK$4.79B
43.17%HK$8.50BHK$6.87B-HK$6.78B-HK$2.97BHK$5.61BHK$4.60B
52.50%HK$8.71BHK$7.05B-HK$7.05B-HK$3.05BHK$5.66BHK$4.38B

Step 3 — Determine the Discount Rate (WACC)

WACC inputValue
Risk-free rate4.71%
Equity risk premium assumption5.50%
Beta0.44
Cost of equity7.15%
Pre-tax cost of debt3.75%
WACC5.84%
WACC validationrequires assumption review

Step 4 — Estimate Terminal Value

Terminal-value inputValue
Perpetuity growth rate2.50%
Terminal valueHK$173.81B
Implied terminal EV / EBITDA10.15x
Terminal value as % of enterprise value84.59%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value componentValue
Present value of explicit FCFFHK$23.84B
Present value of terminal valueHK$130.88B
Indicated enterprise valueHK$154.73B
Discounting conventionmid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridgeValue
Indicated enterprise valueHK$154.73B
Less: gross interest-bearing debtHK$47.09B
Add: cash and equivalentsHK$2.45B
Add: affiliate investmentsHK$0.00
Less: minority interestsHK$1.57B
Indicated common equity valueHK$108.52B

Step 7 — Calculate Indicative Value Per Share

Per-share outputValue
Shares used7,578,646,263.00
Share-count basisreported diluted weighted-average shares
Current market priceHK$12.26
DCF indicative value per shareHK$14.32
Indicative value vs. market price16.80%

Model Integrity Checks

CheckResult
Perpetuity growth is below the risk-free ratepass
Perpetuity growth is below WACCpass
WACC is within the configured operating-company rangereview required
Terminal-year FCFF is positivepass
Terminal capex converges to D&Apass
Terminal-value concentrationwithin review band
Implied price differs from spot by more than 30%within review band

2.6 Investor-Style Research Screen

Educational screenResult
Buffett-inspired cash-quality checks3/4 evidenced checks
Lynch-inspired balance-and-growth checks3/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:10:34.390352 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation inputValue
Regional factor setAsia Pacific ex Japan
Factor-return currencyUSD
Issuer-return basisUSD adjusted total return
Estimation window2025-08-20 to 2026-06-30
Aligned daily observations210
Minimum observation requirement120
Currency conversion for HK listingsHKD adjusted close divided by daily USD/HKD close before simple daily return calculation

Fama–French Three-Factor and Five-Factor Results

DiagnosticFF3FF5
Annualised alpha-6.77%-7.02%
Adjusted R²0.090.09
Annualised residual volatility12.36%12.34%
Factor loading (t-statistic)FF3FF5
Market excess return (Mkt-RF)0.31 (4.46)0.33 (4.40)
Size (SMB)-0.18 (-1.78)-0.14 (-1.05)
Value (HML)0.27 (2.72)0.23 (2.13)
Profitability (RMW)NM-0.05 (-0.39)
Investment (CMA)NM0.12 (0.74)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

hkexstockequity6823